UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 682

Sortiert nach

Atomoxetine and Osmotically Released Methylphenidate for the Treatment of Attention Deficit Hyperactivity Disorder: Acute Comparison and Differential Response

The American journal of psychiatry, 2008-06, Vol.165 (6), p.721-730

2008

Volltextzugriff (PDF)

32.4 THE BIOPHARMACEUTICAL INDUSTRY AND BIG DATA

Journal of the American Academy of Child and Adolescent Psychiatry, 2016-10, Vol.55 (10), p.S308-S309

Allen, Albert J., MD, PhD

2016

Volltextzugriff (PDF)

A review of the abuse potential assessment of atomoxetine: a nonstimulant medication for attention-deficit/hyperactivity disorder

Psychopharmacology, 2013-03, Vol.226 (2), p.189-200

2013

Volltextzugriff (PDF)

Meta-Analysis of Suicide-Related Behavior Events in Patients Treated With Atomoxetine

Journal of the American Academy of Child and Adolescent Psychiatry, 2008-02, Vol.47 (2), p.209-218

2008

Volltextzugriff (PDF)

Characteristics of Placebo Responders in Pediatric Clinical Trials of Attention-Deficit/Hyperactivity Disorder

Journal of the American Academy of Child and Adolescent Psychiatry, 2009-12, Vol.48 (12), p.1165-1172

2009

Volltextzugriff (PDF)

Establishing a global regulatory floor for children's decisions about participation in clinical research

Pediatric research, 2023-08, Vol.94 (2), p.462-465

2023

Volltextzugriff (PDF)

Effects of atomoxetine and methylphenidate on sleep in children with ADHD

Sleep (New York, N.Y.), 2006-12, Vol.29 (12), p.1573-1585

2006

Volltextzugriff (PDF)

Challenges and Opportunities in Bringing New Medications to Market for Pediatric Patients

Journal of the American Academy of Child and Adolescent Psychiatry, 2009-11, Vol.48 (11), p.1056-1059

2009

Volltextzugriff (PDF)

Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies

Biological psychiatry (1969), 2003-01, Vol.53 (2), p.112-120

2003

Volltextzugriff (PDF)

Once-Daily Atomoxetine Treatment for Children and Adolescents With Attention Deficit Hyperactivity Disorder: A Randomized, Placebo-Controlled Study

The American journal of psychiatry, 2002-11, Vol.159 (11), p.1896-1901

2002

Volltextzugriff (PDF)

Meta-Analysis of Aggression or Hostility Events in Randomized, Controlled Clinical Trials of Atomoxetine for ADHD

Biological psychiatry (1969), 2007-03, Vol.61 (5), p.713-719

2007

Volltextzugriff (PDF)

High-Dose Atomoxetine Treatment of ADHD in Youths With Limited Response to Standard Doses

Journal of the American Academy of Child and Adolescent Psychiatry, 2007-09, Vol.46 (9), p.1128-1137

2007

Volltextzugriff (PDF)

Subjective and objective measures of sleep in children with attention-deficit/hyperactivity disorder

Sleep medicine, 2009-04, Vol.10 (4), p.446-456

2009

Volltextzugriff (PDF)

Efficacy and Safety of Atomoxetine Hydrochloride in Asian Adults With ADHD: A Multinational 10-Week Randomized Double-Blind Placebo-Controlled Asian Study

Journal of attention disorders, 2017-01, Vol.21 (2), p.100-109

2017

Volltextzugriff (PDF)

Executive function in adults with attention-deficit/hyperactivity disorder during treatment with atomoxetine in a randomized, placebo-controlled, withdrawal study

Journal of clinical psychopharmacology, 2014-08, Vol.34 (4), p.461-466

2014

Volltextzugriff (PDF)

Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder—A preliminary tolerability and efficacy study

Clinical therapeutics, 2007-06, Vol.29 (6), p.1168-1177

2007

Volltextzugriff (PDF)

Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial

Pediatrics (Evanston), 2004-07, Vol.114 (1), p.e1

2004

Volltextzugriff (PDF)

A pilot study for augmenting atomoxetine with methylphenidate: safety of concomitant therapy in children with attention-deficit/hyperactivity disorder

Child and adolescent psychiatry and mental health, 2007-09, Vol.1 (1), p.10-10, Article 10

2007

Volltextzugriff (PDF)

6.4 REGULATORY AND ETHICAL ISSUES WITH PEDIATRIC PSYCHEDELIC RESEARCH

Journal of the American Academy of Child and Adolescent Psychiatry, 2021-10, Vol.60 (10), p.S10-S10

Allen, Albert J.

2021

Volltextzugriff (PDF)

Abuse liability assessment of atomoxetine in a drug-abusing population

Drug and alcohol dependence, 2008-05, Vol.95 (1), p.140-146

2008

Volltextzugriff (PDF)

A Randomized, Placebo-Controlled Study of Once-Daily Atomoxetine in the School Setting in Children With ADHD

Journal of the American Academy of Child and Adolescent Psychiatry, 2005-07, Vol.44 (7), p.647-655

2005

Volltextzugriff (PDF)

Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections: Clinical Description of the First 50 Cases

The American journal of psychiatry, 1998-02, Vol.155 (2), p.264-271

1998

Volltextzugriff (PDF)

Baseline values from the electrocardiograms of children and adolescents with ADHD

Child and adolescent psychiatry and mental health, 2007-09, Vol.1 (1), p.11-11, Article 11

2007

Volltextzugriff (PDF)

A randomized trial of edivoxetine in pediatric patients with attention-deficit/hyperactivity disorder

Journal of child and adolescent psychopharmacology, 2014-05, Vol.24 (4), p.190

2014

Volltextzugriff (PDF)

Atomoxetine tolerability in pediatric and adult patients receiving different dosing strategies

The journal of clinical psychiatry, 2013-03, Vol.74 (12), p.1217

2013

Volltextzugriff (PDF)

1 – 25 von 682

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(563)
Mit Volltextzugriff
(587)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(393)
Life Sciences & Biomedicine
(335)
Humans
(254)
Male
(154)
Female
(148)
Biological And Medical Sciences
(112)
Medical Sciences
(95)
Adult
(85)
Middle Aged
(72)
Adolescent
(66)
Child
(65)
Psychiatry
(52)
Animals
(50)
Treatment Outcome
(50)
Aged
(48)
Pediatrics
(48)
Double-Blind Method
(43)
Attention Deficit Disorder With Hyperactivity - Drug Therapy
(40)
Pharmacology. Drug Treatments
(40)
Technology
(40)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Atomoxetine and Osmotically Released Methylphenidate for the Treatment of Attention Deficit Hyperactivity Disorder: Acute Comparison and Differential Response

32.4 THE BIOPHARMACEUTICAL INDUSTRY AND BIG DATA

A review of the abuse potential assessment of atomoxetine: a nonstimulant medication for attention-deficit/hyperactivity disorder

Meta-Analysis of Suicide-Related Behavior Events in Patients Treated With Atomoxetine

Characteristics of Placebo Responders in Pediatric Clinical Trials of Attention-Deficit/Hyperactivity Disorder

Establishing a global regulatory floor for children's decisions about participation in clinical research

Effects of atomoxetine and methylphenidate on sleep in children with ADHD

Challenges and Opportunities in Bringing New Medications to Market for Pediatric Patients

Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies

Once-Daily Atomoxetine Treatment for Children and Adolescents With Attention Deficit Hyperactivity Disorder: A Randomized, Placebo-Controlled Study

Meta-Analysis of Aggression or Hostility Events in Randomized, Controlled Clinical Trials of Atomoxetine for ADHD

High-Dose Atomoxetine Treatment of ADHD in Youths With Limited Response to Standard Doses

Subjective and objective measures of sleep in children with attention-deficit/hyperactivity disorder

Efficacy and Safety of Atomoxetine Hydrochloride in Asian Adults With ADHD: A Multinational 10-Week Randomized Double-Blind Placebo-Controlled Asian Study

Executive function in adults with attention-deficit/hyperactivity disorder during treatment with atomoxetine in a randomized, placebo-controlled, withdrawal study

Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder—A preliminary tolerability and efficacy study

Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial

A pilot study for augmenting atomoxetine with methylphenidate: safety of concomitant therapy in children with attention-deficit/hyperactivity disorder

6.4 REGULATORY AND ETHICAL ISSUES WITH PEDIATRIC PSYCHEDELIC RESEARCH

Abuse liability assessment of atomoxetine in a drug-abusing population

A Randomized, Placebo-Controlled Study of Once-Daily Atomoxetine in the School Setting in Children With ADHD

Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections: Clinical Description of the First 50 Cases

Baseline values from the electrocardiograms of children and adolescents with ADHD

A randomized trial of edivoxetine in pediatric patients with attention-deficit/hyperactivity disorder

Atomoxetine tolerability in pediatric and adult patients receiving different dosing strategies

Suchergebnisse filtern